Unexpected Neuroprotective Effects of Loganin on 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Neurotoxicity and Cell Death in Zebrafish

Journal of Cellular Biochemistry

Volumn 118, Issue 3, 2017, Pages 615-628

  Yao, Li ^a   Peng, Shi Xiao ^a   Xu, Yi Da ^a   Lin, Stanley Li ^b   Li, Yu Hong ^a   Liu, Chun Jie ^a   Zhao, Hou De ^a   Wang, Lin Fang ^a   Shen, Yan Qin ^a  

^a JIANGNAN UNIVERSITY   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

LOGANIN; MPTP; NEUROPROTECTION; NEUROTOXICITY; ZEBRAFISH

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; LOGANIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; IRIDOID; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MTOR PROTEIN, RAT; NEUROPROTECTIVE AGENT; TARGET OF RAPAMYCIN KINASE; ZEBRAFISH PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL STRUCTURES; ARTICLE; BRAIN DEVELOPMENT; CELL DEATH; CIRCULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DEVELOPMENTAL DISORDER; DOPAMINERGIC NERVE CELL; DRUG ACTIVITY; DRUG EFFECT; EDEMA; EMBRYO; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; IN SITU HYBRIDIZATION; LARVA; LOCOMOTION; MORPHOLOGY; MPTP-INDUCED PARKINSONISM; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PC12 CELL LINE; PERICARDIUM; PHENOTYPE; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; YOLK SAC; ZEBRA FISH; ANIMAL; EMBRYOLOGY; METABOLISM; MPTP POISONING;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; IRIDOIDS; MAP KINASE KINASE 4; MPTP POISONING; NEUROPROTECTIVE AGENTS; PC12 CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; TOR SERINE-THREONINE KINASES; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84996542524     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25749     Document Type: Article

References (43)

1. Anichtchik OV, Kaslin J, Peitsaro N, Scheinin M, Panula P. 2004. Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurochem 88:443–453.
2. Beal MF. 2001. Experimental models of Parkinson's disease. Nat Rev Neurosci 2:325–334.
3. Betarbet R, Sherer TB, Greenamyre JT. 2002. Animal models of Parkinson's disease. Bioessays 24:308–318.
4. Bretaud S, Lee S, Guo S. 2004. Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease. Neurotoxicol Teratol 26:857–864.
5. Brichese L, Cazettes G, Valette A. 2004. JNK is associated with Bcl-2 and PP1 in mitochondria: Paclitaxel induces its activation and its association with the phosphorylated form of Bcl-2. Cell Cycle 3:1312–1319.
6. Choi J, Rees HD, Weintraub ST, Levey AI, Chin LS, Li L. 2005. Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases. J Biol Chem 280:11648–11655.
7. Deng X, Ruvolo P, Carr B, May WJ. 2000. Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases. Proc Natl Acad Sci USA 97:1578–1583.
8. Diaz-Casado ME, Lima E, Garcia JA, Doerrier C, Aranda P, Sayed RK, Guerra-Librero A, Escames G, Lopez LC, Acuna-Castroviejo D. 2016. Melatonin rescues zebrafish embryos from the parkinsonian phenotype restoring the parkin/PINK1/DJ-1/MUL1 network. J Pineal Res 61:96–107.
9. Endo R, Saito T, Asada A, Kawahara H, Ohshima T, Hisanaga S. 2009. Commitment of 1-methyl-4-phenylpyrinidinium ion-induced neuronal cell death by proteasome-mediated degradation of p35 cyclin-dependent kinase 5 activator. J Biol Chem 284:26029–26039.
10. Frederich M, Choi YH, Angenot L, Harnischfeger G, Lefeber AW, Verpoorte R. 2004. Metabolomic analysis of Strychnos nux-vomica, Strychnos icaja and Strychnos ignatii extracts by 1H nuclear magnetic resonance spectrometry and multivariate analysis techniques. Phytochemistry 65:1993–2001.
11. Grunblatt E, Mandel S, Youdim MB. 2000. MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: Neuroprotective strategies. J Neurol 247(Suppl 2):I95–102.
12. Guo S, Wilson SW, Cooke S, Chitnis AB, Driever W, Rosenthal A. 1999. Mutations in the zebrafish unmask shared regulatory pathways controlling the development of catecholaminergic neurons. Dev Biol 208:473–487.
13. Holzschuh J, Ryu S, Aberger F, Driever W. 2001. Dopamine transporter expression distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing zebrafish embryo. Mech Dev 101:237–243.
14. Kang BP, Urbonas A, Baddoo A, Baskin S, Malhotra A, Meggs LG. 2003. IGF-1 inhibits the mitochondrial apoptosis program in mesangial cells exposed to high glucose. Am J Physiol Renal Physiol 285:F1013–F1024.
15. Kaur C, Ling EA. 2008. Antioxidants and neuroprotection in the adult and developing central nervous system. Curr Med Chem 15:3068–3080.
16. Kim H, Youn K, Ahn MR, Kim OY, Jeong WS, Ho CT, Jun M. 2015. Neuroprotective effect of loganin against Abeta25-35-induced injury via the NF-kappaB-dependent signaling pathway in PC12 cells. Food Funct 6:1108–1116.
17. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. 1995. Stages of embryonic development of the zebrafish. Dev Dyn 203:253–310.
18. Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, Brown WD, Holden JE, Pyzalski R, Taylor MD, Carvey P, Ling Z, Trono D, Hantraye P, Deglon N, Aebischer P. 2000. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290:767–773.
19. Kwon SH, Kim HC, Lee SY, Jang CG. 2009. Loganin improves learning and memory impairments induced by scopolamine in mice. Eur J Pharmacol 619:44–49.
20. Lam CS, Korzh V, Strahle U. 2005. Zebrafish embryos are susceptible to the dopaminergic neurotoxin MPTP. Eur J Neurosci 21:1758–1762.
21. Langston JW, Ballard P, Tetrud JW, Irwin I. 1983. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979–980.
22. Langston JW, Ballard PJ. 1983. Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med 309:310.
23. Li HJ, Li P, Ye WC. 2003. Determination of five major iridoid glucosides in Flos lonicerae by high-performance liquid chromatography coupled with evaporative light scattering detection. J Chromatogr A 1008:167–172.
24. Li M, Wang W, Wang P, Yang K, Sun H, Wang X. 2010. The pharmacological effects of morroniside and loganin isolated from Liuweidihuang Wan, on MC3T3-E1 cells. Molecules 15:7403–7414.
25. Li X, Wang Q, Zhang L, Xu L, Yin W. 2006. HPLC study of tissue distribution of loganin in rats. Biomed Chromatogr 20:1087–1092.
26. McKinley ET, Baranowski TC, Blavo DO, Cato C, Doan TN, Rubinstein AL. 2005. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons. Brain Res Mol Brain Res 141:128–137.
27. Miller GW, Gainetdinov RR, Levey AI, Caron MG. 1999. Dopamine transporters and neuronal injury. Trends Pharmacol Sci 20:424–429.
28. Nicotra A, Parvez SH. 2000. Cell death induced by MPTP, a substrate for monoamine oxidase B. Toxicology 153:157–166.
29. Nogueira V, Park Y, Chen CC, Xu PZ, Chen ML, Tonic I, Unterman T, Hay N. 2008. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14:458–470.
30. Nussbaum RL, Ellis CE. 2003. Alzheimer's disease and Parkinson's disease. N Engl J Med 348:1356–1364.
31. Pollard HB, Dhariwal K, Adeyemo OM, Markey CJ, Caohuy H, Levine M, Markey S, Youdim MB. 1992. A parkinsonian syndrome induced in the goldfish by the neurotoxin MPTP. FASEB J 6:3108–3116.
32. Pollard HB, Kuijpers GA, Adeyemo OM, Youdim MB, Goping G. 1996. The MPTP-induced parkinsonian syndrome in the goldfish is associated with major cell destruction in the forebrain and subtle changes in the optic tectum. Exp Neurol 142:170–178.
33. Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, Akram M. 2001. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): A technical review of its utility and safety. J Neurochem 76:1265–1274.
34. Ramirez AD, Wong SK, Menniti FS. 2003. Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms. Eur J Pharmacol 475:29–35.
35. Rink E, Wullimann MF. 2002. Development of the catecholaminergic system in the early zebrafish brain: An immunohistochemical study. Brain Res Dev Brain Res 137:89–100.
36. Sarath BN, Murthy C, Kakara S, Sharma R, Brahmendra SC, Idris MM. 2016. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease in zebrafish. Proteomics 16:1407–1420.
37. Schroeter H, Boyd CS, Ahmed R, Spencer JP, Duncan RF, Rice-Evans C, Cadenas E. 2003. C-Jun N-terminal kinase (JNK)-mediated modulation of brain mitochondria function: New target proteins for JNK signalling in mitochondrion-dependent apoptosis. Biochem J 372:359–369.
38. Tabner BJ, Turnbull S, El-Agnaf OM, Allsop D. 2002. Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease. Free Radic Biol Med 32:1076–1083.
39. Thisse C, Thisse B, Schilling TF, Postlethwait JH. 1993. Structure of the zebrafish snail1 gene and its expression in wild-type, spadetail and no tail mutant embryos. Development 119:1203–1215.
40. Westerfield M. 2007. The zebrafish book: A guide for the laboratory use of zebrafish (Brachydanio rerio). Eugene, OR: M. Westerfield. p 1.
41. Yamabe N, Noh JS, Park CH, Kang KS, Shibahara N, Tanaka T, Yokozawa T. 2010. Evaluation of loganin, iridoid glycoside from Corni Fructus, on hepatic and renal glucolipotoxicity and inflammation in type 2 diabetic db/db mice. Eur J Pharmacol 648:179–187.
42. Yao L, Liu YH, Li X, Ji YH, Yang XJ, Hang XT, Ding ZM, Liu F, Wang YH, Shen AG. 2016. CRMP1 interacted with Spy1 during the collapse of growth cones induced by Sema3A and acted on regeneration after sciatic nerve crush. Mol Neurobiol 53(2):879–893.
43. Zhang Y, Dawson VL, Dawson TM. 2000. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol Dis 7:240–250.